Company

Second Sight

A retinal prosthesis company that developed Argus II, the first FDA-approved retinal prosthesis, intended to help patients with retinitis pigmentosa regain partial visual perception.

Timeline (last 90 days)

Oct 14

Second Sight's Argus II was the first FDA-approved retinal prosthesis, launched in 2013 and later withdrawn from the market in 2019.

Unverified50%

All Facts (1)

Unverified

Second Sight's Argus II was the first FDA-approved retinal prosthesis, launched in 2013 and later withdrawn from the market in 2019.

50%

Source Articles

Science Corp Implants Vision-Restoration Chip in First Stargardt Disease PatientOct 14